July 2011 - Class Action Blog Archive
Imprelis Herbicide Linked to Tree Damage, Say Reports
DuPont is facing mounting claims that their Imprelis herbicide kills mature trees, including Norway and Colorado spruce, white pines and other evergreens.
SSRIs Linked to Autism, Study Says
According to a new study by the Autism Research Program at Kaiser Permanente, antidepressant use during pregnancy could lead to an increased risk of autism.
Biophosphonate, Fosamax Side Effects to Be Reviewed by FDA
Oral biophosphonates like Fosamax, Actonel, Boniva, and Reclast used to treat osteoporosis have come under evaluation by the FDA.
DePuy ASR Lawsuits Continue to Mount
According to a report by the Wall Street Journal, Johnson & Johnson could be liable for over $1 billion related to the failure of artificial hips manufactured by their subsidiary, DePuy Orthopedics.
POP Mesh Complications Not Rare, Says FDA
An FDA press release has confirmed the long-suspected risks associated with transvaginal placement of surgical meshes for pelvic organ prolapse (POP).
Chantix Linked to Cardiovascular Events
Another report has indicated that smoking cessation drug Chantix (varenicline) has been linked to possible cardiovascular risks.
Infuse Bone Graft Complications Hid by Medtronic Researchers, Study Says
Allegedly, Medtronic, the nation’s largest medical device manufacturer, may have hidden serious side effects of its popular bone growth product Infuse (rhBMP-2).
Zoloft, SSRIs Linked to Birth Defects
A 2007 report by the New England Journal of Medicine showed that that women taking Zoloft while pregnant were up to twice as likely to have a child with certain birth defects as women who took a different class of antidepressants.
Crestor Diabetes Linked to High Doses of the Drug: Study
High doses of Rosuvastatin (Crestor), according to a recent study by the American Medical Association, lead to a greater risk of developing diabetes when compared with smaller doses.